- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02742896
Evaluation for Restoration of Erectile Dysfunction After Cardioversion Treatment Trial
June 3, 2018 updated by: Yong Seog Oh
Erectile and Cognitive function by using the questionnaire and assessment form before sinus conversion
Study Overview
Detailed Description
Sinus conversion by electrical cardioversion increase cardiac output and systemic perfusion.
According to recent reports, maintenance of sinus rhythm increase systemic perfusion which leads to improve renal function.
Therefore, we hypothesized that sinus conversion of patients with atrial fibrillation will increase systemic perfusion which might improve the erectile dysfunction and cognitive dysfunction.
Study Type
Observational
Enrollment (Anticipated)
358
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sung Hwan Kim, professor
- Phone Number: 82-2-2258-1141
- Email: sunghwan@catholic.ac.kr
Study Locations
-
-
Seo Ch-gu
-
Seoul, Seo Ch-gu, Korea, Republic of, 137-701
- Recruiting
- Seoul St Mary's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who are scheduled to rhythm control of persistent atrial fibrillation.
Description
Inclusion Criteria:
- Patients scheduled to electrical cardioversion
Exclusion Criteria:
- Patients have taken any medication for erectile dysfunction or who have got any operation already or are scheduled to do.
- More than moderate degree of cognitive dysfunction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Restoration of Erectile dysfunction
The changes of erectile function by using official questionnaire-The International Index of Erectile Function (IIEF)-5 1 year after conversion to sinus rhythm.
|
The changes of erectile function by using official questionnaire-The International Index of Erectile Function (IIEF)-5 1 year after conversion to sinus rhythm. The changes of cognitive function by using validated assessment form-The Montreal Cognitive assessment (MoCA) 1 year after conversion to sinus rhythm.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The changes of erectile function
Time Frame: Erectile dysfunction 1 year after conversion to sinus rhythm.
|
The changes of erectile function by using official questionnaire-The International Index of Erectile Function (IIEF)-5 1 year after conversion to sinus rhythm.
|
Erectile dysfunction 1 year after conversion to sinus rhythm.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The changes of cognitive function
Time Frame: cognitive dysfunction 1 year after conversion to sinus rhythm
|
The changes of cognitive function by using validated assessment form-The Montreal Cognitive Assessement(MoCA) 1 year after conversion to sinus rhythm
|
cognitive dysfunction 1 year after conversion to sinus rhythm
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Yong Seog Oh, MD, Seoul St Mary hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Anticipated)
April 1, 2019
Study Completion (Anticipated)
October 1, 2019
Study Registration Dates
First Submitted
October 5, 2014
First Submitted That Met QC Criteria
April 13, 2016
First Posted (Estimate)
April 19, 2016
Study Record Updates
Last Update Posted (Actual)
June 6, 2018
Last Update Submitted That Met QC Criteria
June 3, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ERECT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Erectile Dysfunction
-
University of VirginiaActive, not recruitingErectile Dysfunction | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Radiation Therapy | Erectile Dysfunction Due to General Medical Condition | Erectile Dysfunction Due to Arterial InsufficiencyUnited States
-
Cairo UniversityRecruitingErectile Dysfunction | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Simple Prostatectomy | Erectile Dysfunction With Diabetes Mellitus | Erectile Dysfunction Due to Arterial Disease | Erectile Dysfunction Due to Injury | Erectile Dysfunction Due to Neuropathy and other conditionsEgypt
-
University of BaghdadCompletedSexual Dysfunction | Erectile Dysfunction | Erectile Dysfunction Following Radical Prostatectomy | Erectile Dysfunction Following Radiation Therapy | Sexual Abstinence | Erectile Dysfunction With Diabetes Mellitus | Sexual Desire Disorder | Erectile Dysfunction Following Cryotherapy | Erectile Dysfunction... and other conditionsIraq
-
BayerCompletedSexual Dysfunction | Male Erectile DysfunctionBelgium, Italy, France, Germany, Spain, Netherlands, South Africa
-
Cairo UniversityCompletedVasculogenic Erectile DysfunctionEgypt
-
InitiaTerminatedVasculogenic Erectile DysfunctionIsrael
-
InitiaCompletedVasculogenic Erectile DysfunctionIsrael
-
InitiaCompletedVasculogenic Erectile DysfunctionCzech Republic, Lithuania, Netherlands, Palestinian Territories, Occupied
-
Rexahn Pharmaceuticals, Inc.CompletedErectile Dysfunction (ED)United States
-
SK Chemicals Co., Ltd.TerminatedMale Erectile Dysfunction
Clinical Trials on Erectile dysfunction
-
Kuang Tien General HospitalNational Central University, Taiwan; Asia UniversityCompleted
-
Institut BergoniéTerminatedRectal Cancer Stage IFrance
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompleted
-
Copenhagen University Hospital at HerlevCompletedPostoperative Complications | Erectile Dysfunction | Intraoperative ComplicationsDenmark
-
University of StellenboschStanley Medical Research InstituteCompleted
-
Duke UniversityNational Cancer Institute (NCI)Completed
-
University Hospital, GhentCompleted
-
Imperial College LondonMalaysia Palm Oil BoardCompletedHealthy VolunteersUnited Kingdom
-
University of VirginiaDIREX SYSTEMS CORPORATIONWithdrawnVasculogenic Erectile Dysfunction
-
University of MiamiDIREX SYSTEMS CORPORATIONCompletedVasculogenic Erectile DysfunctionUnited States